Your shopping cart is currently empty

GV-196771A A novel NMDA receptor glycine site antagonist with potent antinociceptive activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $700 | - | In Stock | |
| 5 mg | $1,800 | - | In Stock |
| Description | GV-196771A A novel NMDA receptor glycine site antagonist with potent antinociceptive activity. |
| In vivo | GV196771A, developed for the treatment of neuropathic pain, is a potent antagonist of the modulatory glycine site of the N-methyl-D-aspartate receptor (NMDA receptor). It exhibits low oral bioavailability in rats and mice, with a bioavailability of less than 10% and a plasma clearance of approximately 2 mL/min/kg[1]. |
| Molecular Weight | 423.23 |
| Formula | C20H13Cl2N2NaO3 |
| Cas No. | 166974-23-8 |
| Smiles | [O-]C(C1=C(C2=C(Cl)C=C(Cl)C=C2N1)/C=C3C(N(C4=CC=CC=C4)CC/3)=O)=O.[Na+] |
| Relative Density. | no data available |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.